Cargando…

Oral vancomycin desensitisation to treat Clostridium difficile infection in a vancomycin allergic patient

The prevalence of Clostridium difficile infection (CDI) is increasing worldwide. Oral vancomycin is an effective and frequently used treatment. However, patients with CDI who are allergic to intravenous vancomycin cannot receive oral vancomycin due to the risk of anaphylaxis if given the oral form....

Descripción completa

Detalles Bibliográficos
Autores principales: Mahabir, Shanti, Lim, Ren Yik, Fitzpatrick, Fidelma, Magee, Colm, Keogan, Mary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: World Allergy Organization 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3850779/
https://www.ncbi.nlm.nih.gov/pubmed/24079362
http://dx.doi.org/10.1186/1939-4551-6-16
_version_ 1782294158251130880
author Mahabir, Shanti
Lim, Ren Yik
Fitzpatrick, Fidelma
Magee, Colm
Keogan, Mary
author_facet Mahabir, Shanti
Lim, Ren Yik
Fitzpatrick, Fidelma
Magee, Colm
Keogan, Mary
author_sort Mahabir, Shanti
collection PubMed
description The prevalence of Clostridium difficile infection (CDI) is increasing worldwide. Oral vancomycin is an effective and frequently used treatment. However, patients with CDI who are allergic to intravenous vancomycin cannot receive oral vancomycin due to the risk of anaphylaxis if given the oral form. We present a case where oral vancomycin desensitisation was used to successfully treat a vancomycin allergic patient with recurrent CDI.
format Online
Article
Text
id pubmed-3850779
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher World Allergy Organization
record_format MEDLINE/PubMed
spelling pubmed-38507792013-12-05 Oral vancomycin desensitisation to treat Clostridium difficile infection in a vancomycin allergic patient Mahabir, Shanti Lim, Ren Yik Fitzpatrick, Fidelma Magee, Colm Keogan, Mary World Allergy Organ J Case Report The prevalence of Clostridium difficile infection (CDI) is increasing worldwide. Oral vancomycin is an effective and frequently used treatment. However, patients with CDI who are allergic to intravenous vancomycin cannot receive oral vancomycin due to the risk of anaphylaxis if given the oral form. We present a case where oral vancomycin desensitisation was used to successfully treat a vancomycin allergic patient with recurrent CDI. World Allergy Organization 2013-09-30 /pmc/articles/PMC3850779/ /pubmed/24079362 http://dx.doi.org/10.1186/1939-4551-6-16 Text en Copyright © 2013 Mahabir et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Mahabir, Shanti
Lim, Ren Yik
Fitzpatrick, Fidelma
Magee, Colm
Keogan, Mary
Oral vancomycin desensitisation to treat Clostridium difficile infection in a vancomycin allergic patient
title Oral vancomycin desensitisation to treat Clostridium difficile infection in a vancomycin allergic patient
title_full Oral vancomycin desensitisation to treat Clostridium difficile infection in a vancomycin allergic patient
title_fullStr Oral vancomycin desensitisation to treat Clostridium difficile infection in a vancomycin allergic patient
title_full_unstemmed Oral vancomycin desensitisation to treat Clostridium difficile infection in a vancomycin allergic patient
title_short Oral vancomycin desensitisation to treat Clostridium difficile infection in a vancomycin allergic patient
title_sort oral vancomycin desensitisation to treat clostridium difficile infection in a vancomycin allergic patient
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3850779/
https://www.ncbi.nlm.nih.gov/pubmed/24079362
http://dx.doi.org/10.1186/1939-4551-6-16
work_keys_str_mv AT mahabirshanti oralvancomycindesensitisationtotreatclostridiumdifficileinfectioninavancomycinallergicpatient
AT limrenyik oralvancomycindesensitisationtotreatclostridiumdifficileinfectioninavancomycinallergicpatient
AT fitzpatrickfidelma oralvancomycindesensitisationtotreatclostridiumdifficileinfectioninavancomycinallergicpatient
AT mageecolm oralvancomycindesensitisationtotreatclostridiumdifficileinfectioninavancomycinallergicpatient
AT keoganmary oralvancomycindesensitisationtotreatclostridiumdifficileinfectioninavancomycinallergicpatient